Biogen Pharmachem Industries Ltd
Biogen Pharmachem Industries Ltd (BIOGEN) last traded at ₹0.28, a market capitalisation of ₹29.5 crore. Over the past 52 weeks the stock has ranged between ₹0.26 and ₹0.8. Biogen Pharmachem Industries Ltd last reported results for the quarter ended Jun 2026, with sales of ₹0.44 crore and net profit of ₹0.22 crore. Figures are as of 25 Aug 2026 and are not real time.
Biogen Pharmachem Industries Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Biogen Pharmachem Industries Ltd quarterly results
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 1.35 | 0 | 0 | 0.54 | 0.58 | 0.44 |
| Expenses | 0.35 | 0.54 | 0.17 | 0.2 | 0.39 | 0.08 | 0.94 | 0.22 |
| Operating profit | -0.35 | -0.54 | 1.18 | -0.2 | -0.39 | 0.46 | -0.36 | 0.22 |
| OPM % | — | — | 87.41% | — | — | 85.19% | -62.07% | 50.00% |
| Other income | -0.65 | 0.23 | 0 | 1.54 | -0.1 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -1 | -0.31 | 1.18 | 1.34 | -0.49 | 0.46 | -0.36 | 0.22 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net profit | -1 | -0.31 | 1.18 | 1.34 | -0.49 | 0.46 | -0.36 | 0.22 |
| EPS (₹) | -0.01 | -0.00 | 0.02 | 0.01 | -0.00 | 0.00 | -0.00 | 0.00 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Biogen Pharmachem Industries Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 1.62 | 2.47 | 0 | 2.38 | 1.2 | 2.56 | 1.56 |
| Operating profit | -1.6 | -0.02 | -0.45 | 1.93 | -0.29 | 0.96 | -0.07 |
| OPM % | -98.77% | -0.81% | — | 81.09% | -24.17% | 37.50% | -4.49% |
| Net profit | -1.6 | -0.01 | 0.46 | 1.93 | -0.29 | 0.86 | -0.17 |
| EPS (₹) | -0.02 | -0.00 | 0.01 | 0.03 | -0.00 | 0.01 | 0.00 |
TTM is the trailing twelve months to the most recent quarter.
Biogen Pharmachem Industries Ltd growth and returns
- 10 Years
- %
- 5 Years
- 10%
- 3 Years
- %
- TTM
- 16%
- 10 Years
- 41%
- 5 Years
- 20%
- 3 Years
- 85%
- TTM
- -114%
- 10 Years
- 4%
- 5 Years
- -13%
- 3 Years
- -26%
- 1 Year
- -64%
- 10 Years
- -1%
- 5 Years
- 1%
- 3 Years
- 1%
- Last Year
- 1%
Biogen Pharmachem Industries Ltd shareholding pattern
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Public | 99.99% | 100.00% | 99.99% | 100.00% | 100.00% | 100.00% | 99.99% | 100.00% |
| No. of shareholders | 2,80,600 | 3,03,780 | 3,02,362 | 2,98,703 | 2,93,327 | 2,89,987 | 2,89,155 | 2,93,626 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Biogen Pharmachem Industries Ltd corporate filings
- PFACompany Updatelow impact
Cruxal's analysis: Biogen Pharmachem Industries Ltd has submitted a disclosure under Regulation 32(1) of the…
Read the full analysis - Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors ....Board Meetingmedium impact
Cruxal's analysis: Biogen Pharmachem Industries Limited reported a sharp decline in revenue from operations…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Biogen Pharmachem Industries Ltd
Cruxal reads every Biogen Pharmachem Industries Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.